Skip to content

Comparison of the effectiveness of retrolaminar block and medial cervical branch block in the treatment of cervical facet joint arthropathy: a randomized controlled trial.

Comparison of the effectiveness of retrolaminar block and medial cervical branch block in the treatment of cervical facet joint arthropathy: a randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250925067357N1
Enrollment
22
Registered
2025-11-04
Start date
2025-08-23
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical facet joint arthropathy. Spondylosis without myelopathy or radiculopathy, cervical region

Interventions

Intervention 1: Intervention group: Cervical retrolaminar block. Intervention 2: Control group: Cervical medial cervical branch block.

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age over 30 years. - Diagnosis of cervical facet joint arthropathy based on physical examination - BMI less than 30. - Pain score (NRS) = 4. - ASA physical status class I or II.

Exclusion criteria

Exclusion criteria: - Patient's refusal to continue participation. - Presence of sepsis, bleeding disorders, unstable respiratory or cardiovascular problems. - History of drug or substance abuse, allergy to medications used (lidocaine, dexamethasone). - Local anatomical abnormalities or history of severe neurological/psychiatric disorders.

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: First week, first month, third month after completing the block. Method of measurement: Numerical Rating Scale.;Functional status of the neck. Timepoint: First week, first month, third month after completing the block. Method of measurement: Neck Disability Index.

Secondary

MeasureTime frame
Side effects. Timepoint: After the procedure. Method of measurement: Patient's clinical symptoms.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatane Jamshidi

Tehran University of Medical Sciences

fatanejamshidi@gmail.com+98 21 2209 1472

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026